Mj. Andradaserpa et al., IMMUNOLOGICAL FEATURES OF HTLV-I MYELOPATHY IN RIO-DE-JANEIRO, BRAZIL, AND IN-VITRO EFFECTS OF CYCLOSPORINE-A, Journal of the neurological sciences, 139(1), 1996, pp. 7-14
Brazilian patients with HTLV-1 myelopathy present a significant sponta
neous lymphocyte proliferation (SLP), and an increased response to IL-
2 exogenous stimulation, in both peripheral blood lymphocytes and in w
hole blood proliferative assays, when compared to the control group. H
igh antibody titers against HTLV-I antigens were also observed in comp
arison to healthy seropositive individuals. IL-6 was detected in cereb
rospinal fluid (CSF) of 50% of the patients (10 out of 20) and TNF-alp
ha in four out of nineteen individuals. No correlation was found betwe
en the presence of levels of cytokines n-6 and TNF-alpha and duration
or severity of disease. The addition of cyclosporin A (CsA) significan
tly inhibited SLP suggesting that this therapeutic agent should be stu
died in HTLV-1 myelopathy. Brazilian patients with HTLV-I myelopathy p
resent the same immunological abnormalities described in other endemic
regions. The whole blood assay reflects the same results of separated
blood cells and, due to its rapid execution may be used as an assay t
o follow clinical trials.